In the examined early stage NSCLC cohort we did not found any correlation of Ephrin B3 expression per se and patient overall survival yet we found Ephrin B3 to have a higher expression in NSCLC specimen alongside EphA2. Here, EPHA2 is linked to non-small cell lung carcinoma.